ResearcherShandong UniversityNo recent work listed

Dayong Shi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8941-5285; OpenAlex author ID A5020417557. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2019: 1 paper

Papers 1

Inhibition of PTP1B blocks pancreatic cancer progression by targeting the PKM2/AMPK/mTOC1 pathway. Last author DOI 10.1038/s41419-019-2073-4 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ning Wu · 1 shared paper, 2019 · strength 0.10
- Paper Inhibition of PTP1B blocks pancreatic cancer progression by targeting the PKM2/AMPK/mTOC1 pathway. DOI 10.1038/s41419-019-2073-4 ↗
Chuanlong Guo · 1 shared paper, 2019 · strength 0.10
- Paper Inhibition of PTP1B blocks pancreatic cancer progression by targeting the PKM2/AMPK/mTOC1 pathway. DOI 10.1038/s41419-019-2073-4 ↗
Qi Xu · 1 shared paper, 2019 · strength 0.10
- Paper Inhibition of PTP1B blocks pancreatic cancer progression by targeting the PKM2/AMPK/mTOC1 pathway. DOI 10.1038/s41419-019-2073-4 ↗
Huaizhi Wang · 1 shared paper, 2019 · strength 0.10
- Paper Inhibition of PTP1B blocks pancreatic cancer progression by targeting the PKM2/AMPK/mTOC1 pathway. DOI 10.1038/s41419-019-2073-4 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.